The high predictive power of the ROC curve (MUO AUC of 96.7%) suggests that a combination of metabolic markers (e.g., PI (16:0/14:1) and treosulfan) and liver function markers (ALT) can effectively distinguish MHO and MUO obesity. The gene discussed is GPT; the disease is obesity disorder.